These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 14722895)

  • 1. Spread of hepatitis C virus among European injection drug users infected with HIV: a phylogenetic analysis.
    van Asten L; Verhaest I; Lamzira S; Hernandez-Aguado I; Zangerle R; Boufassa F; Rezza G; Broers B; Robertson JR; Brettle RP; McMenamin J; Prins M; Cochrane A; Simmonds P; Coutinho RA; Bruisten S;
    J Infect Dis; 2004 Jan; 189(2):292-302. PubMed ID: 14722895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple Introduction and Naturally Occuring Drug Resistance of HCV among HIV-Infected Intravenous Drug Users in Yunnan: An Origin of China's HIV/HCV Epidemics.
    Chen M; Ma Y; Chen H; Luo H; Dai J; Song L; Yang C; Mei J; Yang L; Dong L; Jia M; Lu L
    PLoS One; 2015; 10(11):e0142543. PubMed ID: 26562015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C virus subtypes circulating among intravenous drug users in Lisbon, Portugal.
    Calado RA; Rocha MR; Parreira R; Piedade J; Venenno T; Esteves A
    J Med Virol; 2011 Apr; 83(4):608-15. PubMed ID: 21328374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subtype distribution of hepatitis C virus in Jiangsu, China.
    Qi Y; Chen Q; Hao F; Wan Z; Guo H; Lu R; Mao L; Du H; Lu J; Zhang C
    J Med Virol; 2016 Mar; 88(3):498-505. PubMed ID: 26288243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple routes of hepatitis C virus transmission among injection drug users in Hai Phong, Northern Vietnam.
    Tanimoto T; Nguyen HC; Ishizaki A; Chung PT; Hoang TT; Nguyen VT; Kageyama S; Oka S; Pham VT; Ichimura H
    J Med Virol; 2010 Aug; 82(8):1355-63. PubMed ID: 20572071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C virus genotype 3A in a population of injecting drug users in Montenegro: Bayesian and evolutionary analysis.
    Mugosa B; Cella E; Lai A; Lo Presti A; Blasi A; Vratnica Z; Vujoševic D; Ebranati E; Lauševic D; Guarino M; Zehender G; Milano T; Pascarella S; Spoto S; Angeletti S; Ciccozzi M
    Arch Virol; 2017 Jun; 162(6):1549-1561. PubMed ID: 28194580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of widespread methadone treatment on the molecular epidemiology of hepatitis C virus infection among injection drug users in Hong Kong.
    Chan DP; Lee SS; Lee KC
    J Med Virol; 2011 Jul; 83(7):1187-94. PubMed ID: 21567422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Genetic variants of hepatitis C virus in HIV-infected drug users].
    Bobkova MR; Samokhvalov EI; Kravchenko AV; Salamov GG; Zverev SIa; Pokrovskiĭ VV; L'vov DK
    Vopr Virusol; 2002; 47(3):15-20. PubMed ID: 12173428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular epidemiology of HCV monoinfection and HIV/HCV coinfection in injection drug users in Liuzhou, Southern China.
    Tan Y; Wei QH; Chen LJ; Chan PC; Lai WS; He ML; Kung HF; Lee SS
    PLoS One; 2008; 3(10):e3608. PubMed ID: 18974888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evolutionary characteristics and positive selection site of hepatitis C virus isolated in intravenous drug users in Pudong new district, Shanghai].
    Wang Y; Wu HY; Zhao XC; Zhu WP; Wan Q; Lu YH; Jiang QW
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Mar; 38(3):378-383. PubMed ID: 28329944
    [No Abstract]   [Full Text] [Related]  

  • 11. The Molecular Epidemiological Study of HCV Subtypes among Intravenous Drug Users and Non-Injection Drug Users in China.
    Tao J; Liang J; Zhang H; Pei L; Qian HZ; Chambers MC; Jiang Y; Xiao Y
    PLoS One; 2015; 10(10):e0140263. PubMed ID: 26466103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular characterization of human immunodeficiency virus type 1 and hepatitis C virus in paid blood donors and injection drug users in china.
    Zhang L; Chen Z; Cao Y; Yu J; Li G; Yu W; Yin N; Mei S; Li L; Balfe P; He T; Ba L; Zhang F; Lin HH; Yuen MF; Lai CL; Ho DD
    J Virol; 2004 Dec; 78(24):13591-9. PubMed ID: 15564470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tracking the entry routes of hepatitis C virus as a surrogate of HIV in an HIV-low prevalence country, the Philippines.
    Kageyama S; Agdamag DM; Alesna ET; Abellanosa-Tac-An IP; Corpuz AC; Telan EF; Que ER; Leaño PS; Jereza LD; Emphasis YE; Prasetyo AA; Tanimoto T; Ichimura H
    J Med Virol; 2009 Jul; 81(7):1157-62. PubMed ID: 19475613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular epidemiology of hepatitis C virus in a social network of injection drug users.
    Aitken CK; McCaw RF; Bowden DS; Tracy SL; Kelsall JG; Higgs PG; Kerger MJ; Nguyen H; Crofts JN
    J Infect Dis; 2004 Nov; 190(9):1586-95. PubMed ID: 15478062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombination in hepatitis C virus is not uncommon among people who inject drugs in Kolkata, India.
    Gupta D; Saha K; Biswas A; Firdaus R; Ghosh M; Sadhukhan PC
    Infect Genet Evol; 2017 Mar; 48():156-163. PubMed ID: 27923769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HCV dispersal patterns among intravenous drug users (IDUs) in Athens metropolitan area.
    Papachristou E; Tsagkovits A; Zavitsanou A; Hatzakis A; Paraskevis D
    Infect Genet Evol; 2016 Nov; 45():415-419. PubMed ID: 27721034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phylogenetic analysis of hepatitis C virus strains and risk factors associated with infection and viral subtypes among Iranian patients.
    Salehi Moghadam F; Mohebbi SR; Hosseini SM; Romani S; Mirtalebi H; Azimzadeh P; Damavand B; Naghoosi H; Khanyaghma M; Sanati A; Zali MR
    J Med Virol; 2014 Aug; 86(8):1342-9. PubMed ID: 24838700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular epidemiology and genetic history of hepatitis C virus subtype 3a infection in Thailand.
    Akkarathamrongsin S; Hacharoen P; Tangkijvanich P; Theamboonlers A; Tanaka Y; Mizokami M; Poovorawan Y
    Intervirology; 2013; 56(5):284-94. PubMed ID: 23838334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complex patterns of HCV epidemic in Suzhou: evidence for dual infection and HCV recombination in East China.
    Du H; Qi Y; Hao F; Huang Y; Mao L; Ji S; Huang M; Qin C; Yan R; Zhu X; Zhang C
    J Clin Virol; 2012 Jul; 54(3):207-12. PubMed ID: 22595306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HCV subtype characterization among injection drug users: implication for a crucial role of Zhenjiang in HCV transmission in China.
    Zhang C; Wu N; Liu J; Ge Q; Huang Y; Ren Q; Feng Q; He G
    PLoS One; 2011 Feb; 6(2):e16817. PubMed ID: 21304823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.